When MPCC were treated with FFA, HGF, or FFA + HGF, all media induced significant hepatic steatosis as compared to control wells (Fig. 2B–D, quantified in H–J), however, the induction latency and magnitude of steatosis differed between treatment groups. This evidence concerns the gene HGF and fatty liver disease.